235 related articles for article (PubMed ID: 33042280)
1. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
2. Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas.
Gibbs-Strauss SL; Samkoe KS; O'Hara JA; Davis SC; Hoopes PJ; Hasan T; Pogue BW
Acad Radiol; 2010 Jan; 17(1):7-17. PubMed ID: 19796971
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Glioma Detection Using an EGFR-Targeted Fluorescent Affibody.
Ribeiro de Souza AL; Marra K; Gunn J; Samkoe KS; Hull S; Paulsen KD; Pogue BW
Photochem Photobiol; 2018 Nov; 94(6):1167-1171. PubMed ID: 30129069
[TBL] [Abstract][Full Text] [Related]
4. Examining the Feasibility of Quantifying Receptor Availability Using Cross-Modality Paired-Agent Imaging.
Meng B; Sadeghipour N; Folaron MR; Strawbridge RR; Samkoe KS; Tichauer KM; Davis SC
Mol Imaging Biol; 2022 Feb; 24(1):23-30. PubMed ID: 34286423
[TBL] [Abstract][Full Text] [Related]
5. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.
Manning HC; Merchant NB; Foutch AC; Virostko JM; Wyatt SK; Shah C; McKinley ET; Xie J; Mutic NJ; Washington MK; LaFleur B; Tantawy MN; Peterson TE; Ansari MS; Baldwin RM; Rothenberg ML; Bornhop DJ; Gore JC; Coffey RJ
Clin Cancer Res; 2008 Nov; 14(22):7413-22. PubMed ID: 19010858
[TBL] [Abstract][Full Text] [Related]
7. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor imaging in human head and neck cancer xenografts.
van Dijk LK; Boerman OC; Kaanders JH; Bussink J
Acta Oncol; 2015; 54(9):1263-7. PubMed ID: 26248024
[TBL] [Abstract][Full Text] [Related]
9. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer.
McKnight BN; Kim S; Boerner JL; Viola NT
Breast Cancer Res; 2020 Apr; 22(1):37. PubMed ID: 32295603
[TBL] [Abstract][Full Text] [Related]
11. 111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.
van Dijk LK; Hoeben BA; Stegeman H; Kaanders JH; Franssen GM; Boerman OC; Bussink J
Radiother Oncol; 2013 Sep; 108(3):484-8. PubMed ID: 23932156
[TBL] [Abstract][Full Text] [Related]
12. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
Yamaguchi A; Achmad A; Hanaoka H; Heryanto YD; Bhattarai A; Ratianto ; Khongorzul E; Shintawati R; Kartamihardja AAP; Kanai A; Sugo Y; S Ishioka N; Higuchi T; Tsushima Y
BMC Cancer; 2019 Oct; 19(1):1000. PubMed ID: 31651282
[TBL] [Abstract][Full Text] [Related]
13. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
[TBL] [Abstract][Full Text] [Related]
14. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
15. Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.
Burley TA; Da Pieve C; Martins CD; Ciobota DM; Allott L; Oyen WJG; Harrington KJ; Smith G; Kramer-Marek G
J Nucl Med; 2019 Mar; 60(3):353-361. PubMed ID: 30213849
[TBL] [Abstract][Full Text] [Related]
16. Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Paulsen KD; Pogue BW
J Biomed Opt; 2010; 15(5):051602. PubMed ID: 21054076
[TBL] [Abstract][Full Text] [Related]
17. Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR:2377.
Mitran B; Andersson KG; Lindström E; Garousi J; Rosestedt M; Tolmachev V; Ståhl S; Orlova A; Löfblom J
Oncol Rep; 2019 Jan; 41(1):534-542. PubMed ID: 30320363
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
19. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive imaging of dual-agent uptake in glioma and normal tissue using MRI-coupled fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10874():. PubMed ID: 31929675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]